Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model
Abstract Background The study aimed to evaluate the efficacy and safety of gingival mesenchymal stem cells (GMSCs) from human fetal gingival tissue used for treating gingival defects in a rat model. Methods GMSCs were isolated from human fetal gingival tissue and identified by flow cytometry for nes...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-017-0751-7 |
id |
doaj-f13e94e63ac443bcb12b4e06fc90c9af |
---|---|
record_format |
Article |
spelling |
doaj-f13e94e63ac443bcb12b4e06fc90c9af2020-11-24T21:21:42ZengBMCStem Cell Research & Therapy1757-65122018-02-01911810.1186/s13287-017-0751-7Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat modelJing Li0Shi-qing Xu1Kai Zhang2Wen-jian Zhang3Hong-lin Liu4Zhen Xu5Hong Li6Jin-ning Lou7Li-hong Ge8Bao-hua Xu9Dental Medical Center, China–Japan Friendship HospitalInstitute of Clinical Medical Sciences, China–Japan Friendship HospitalDental Medical Center, China–Japan Friendship HospitalInstitute of Clinical Medical Sciences, China–Japan Friendship HospitalInstitute of Clinical Medical Sciences, China–Japan Friendship HospitalDental Medical Center, China–Japan Friendship HospitalInstitute of Clinical Medical Sciences, China–Japan Friendship HospitalInstitute of Clinical Medical Sciences, China–Japan Friendship HospitalDepartment of Pediatric Dentistry, Peking University School and Hospital of StomatologyDental Medical Center, China–Japan Friendship HospitalAbstract Background The study aimed to evaluate the efficacy and safety of gingival mesenchymal stem cells (GMSCs) from human fetal gingival tissue used for treating gingival defects in a rat model. Methods GMSCs were isolated from human fetal gingival tissue and identified by flow cytometry for nestin, Oct4, vimentin, NANOG, CD105, and CD90. The immunogenicity of GMSCs was analyzed by mixed lymphocyte reactions; the tumorigenicity of GMSCs was evaluated by xenotransplanting into nude mice. The gingival defect animal model was established by mechanical resection in rats. GMSCs were transplanted into the defective area, and the regeneration of gingival tissue was observed twice weekly. Four weeks after transplantation, the gingival tissue was surgically cut down, and the graft was analyzed by immunohistochemistry staining for human mitochondrial antigens and rat CD3 and CD20. Results GMSCs from human fetal gingival tissue positively expressed nestin, Oct4, vimentin, NANOG, CD105, and CD90. There was no cell aggregation after mixed lymphocyte reactions, and interleukin-2 did not increase. Inoculation of GMSCs into nude mice for 6 months showed no tumor formation. GMSCs were transplanted into the gingiva defects of rats. One week after transplantation, the defect area was reduced, and after 3 weeks the morphology and color of local gingival tissue was similar to normal gingival tissue, and gingival height was the same as the normal control group. Conclusions Using GMSCs from human fetal gingival tissue to treat gingival defects is a safe and effective innovative treatment method.http://link.springer.com/article/10.1186/s13287-017-0751-7Gingival defectGingival mesenchymal stem cellsFetal stem cellsTransplantation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jing Li Shi-qing Xu Kai Zhang Wen-jian Zhang Hong-lin Liu Zhen Xu Hong Li Jin-ning Lou Li-hong Ge Bao-hua Xu |
spellingShingle |
Jing Li Shi-qing Xu Kai Zhang Wen-jian Zhang Hong-lin Liu Zhen Xu Hong Li Jin-ning Lou Li-hong Ge Bao-hua Xu Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model Stem Cell Research & Therapy Gingival defect Gingival mesenchymal stem cells Fetal stem cells Transplantation |
author_facet |
Jing Li Shi-qing Xu Kai Zhang Wen-jian Zhang Hong-lin Liu Zhen Xu Hong Li Jin-ning Lou Li-hong Ge Bao-hua Xu |
author_sort |
Jing Li |
title |
Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model |
title_short |
Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model |
title_full |
Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model |
title_fullStr |
Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model |
title_full_unstemmed |
Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model |
title_sort |
treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model |
publisher |
BMC |
series |
Stem Cell Research & Therapy |
issn |
1757-6512 |
publishDate |
2018-02-01 |
description |
Abstract Background The study aimed to evaluate the efficacy and safety of gingival mesenchymal stem cells (GMSCs) from human fetal gingival tissue used for treating gingival defects in a rat model. Methods GMSCs were isolated from human fetal gingival tissue and identified by flow cytometry for nestin, Oct4, vimentin, NANOG, CD105, and CD90. The immunogenicity of GMSCs was analyzed by mixed lymphocyte reactions; the tumorigenicity of GMSCs was evaluated by xenotransplanting into nude mice. The gingival defect animal model was established by mechanical resection in rats. GMSCs were transplanted into the defective area, and the regeneration of gingival tissue was observed twice weekly. Four weeks after transplantation, the gingival tissue was surgically cut down, and the graft was analyzed by immunohistochemistry staining for human mitochondrial antigens and rat CD3 and CD20. Results GMSCs from human fetal gingival tissue positively expressed nestin, Oct4, vimentin, NANOG, CD105, and CD90. There was no cell aggregation after mixed lymphocyte reactions, and interleukin-2 did not increase. Inoculation of GMSCs into nude mice for 6 months showed no tumor formation. GMSCs were transplanted into the gingiva defects of rats. One week after transplantation, the defect area was reduced, and after 3 weeks the morphology and color of local gingival tissue was similar to normal gingival tissue, and gingival height was the same as the normal control group. Conclusions Using GMSCs from human fetal gingival tissue to treat gingival defects is a safe and effective innovative treatment method. |
topic |
Gingival defect Gingival mesenchymal stem cells Fetal stem cells Transplantation |
url |
http://link.springer.com/article/10.1186/s13287-017-0751-7 |
work_keys_str_mv |
AT jingli treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel AT shiqingxu treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel AT kaizhang treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel AT wenjianzhang treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel AT honglinliu treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel AT zhenxu treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel AT hongli treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel AT jinninglou treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel AT lihongge treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel AT baohuaxu treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel |
_version_ |
1725998661726371840 |